PL437901A1 - Probówka do wytwarzania fibryny bogatopłytkowej oraz sposób wytwarzania fibryny bogatopłytkowej - Google Patents
Probówka do wytwarzania fibryny bogatopłytkowej oraz sposób wytwarzania fibryny bogatopłytkowejInfo
- Publication number
- PL437901A1 PL437901A1 PL437901A PL43790121A PL437901A1 PL 437901 A1 PL437901 A1 PL 437901A1 PL 437901 A PL437901 A PL 437901A PL 43790121 A PL43790121 A PL 43790121A PL 437901 A1 PL437901 A1 PL 437901A1
- Authority
- PL
- Poland
- Prior art keywords
- rich fibrin
- producing platelet
- platelet
- test tube
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5002—Partitioning blood components
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Wynalazek dotyczy probówki do wytwarzania fibryny bogatopłytkowej (PRF) zawierającej czynniki wspomagające krzepnięcie krwi, znajdującej zastosowanie w medycynie regeneracyjnej i estetycznej oraz w chirurgii stomatologicznej, która zawiera mieszaninę izolowanego lub rekombinowanego ludzkiego czynnika von Willebranda (VWF) oraz izolowanego lub rekombinowanego ludzkiego czynnika VIII krzepnięcia (FVIII) użytych w proporcji 1 : 1-2. Przedmiotem wynalazku jest również sposób wytwarzania fibryny bogatopłytkowej (PRF).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL437901A PL249414B1 (pl) | 2021-05-19 | 2021-05-19 | Sposób wytwarzania fibryny bogatopłytkowej |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL437901A PL249414B1 (pl) | 2021-05-19 | 2021-05-19 | Sposób wytwarzania fibryny bogatopłytkowej |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL437901A1 true PL437901A1 (pl) | 2022-11-21 |
| PL249414B1 PL249414B1 (pl) | 2026-04-13 |
Family
ID=84191890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL437901A PL249414B1 (pl) | 2021-05-19 | 2021-05-19 | Sposób wytwarzania fibryny bogatopłytkowej |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL249414B1 (pl) |
-
2021
- 2021-05-19 PL PL437901A patent/PL249414B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL249414B1 (pl) | 2026-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Afat et al. | Effects of leukocyte-and platelet-rich fibrin alone and combined with hyaluronic acid on early soft tissue healing after surgical extraction of impacted mandibular third molars: A prospective clinical study | |
| Piot et al. | Management of dental extractions in patients with bleeding disorders | |
| Giannini et al. | Comparison between PRP, PRGF and PRF: lights and shadows in three similar but different protocols | |
| Athanasiadis et al. | Effects of topical antifibrinolytics in endoscopic sinus surgery: a pilot randomized controlled trial | |
| ATE442373T1 (de) | Nukleotid- und proteinsequenzen von delta-genen von vertebraten und darauf basierende methoden | |
| Schmugge et al. | Platelets and von Willebrand factor | |
| GRALNICK et al. | Platelet von Willebrand factor | |
| MX2024013781A (es) | Composición farmacéutica de la proteína de fusión del vegfr | |
| PL437901A1 (pl) | Probówka do wytwarzania fibryny bogatopłytkowej oraz sposób wytwarzania fibryny bogatopłytkowej | |
| AU2003274686A8 (en) | Inhibitors of the gpib -vwf interaction, their preparation and use | |
| FOHSBEHC | Transplantation of os purum and bone chips in the surgical treatment of periodontal disease | |
| CO2023017358A2 (es) | Formulaciones de proteínas quiméricas del factor viii y usos de las mismas | |
| Gandhi et al. | MIDAS (Minimally Invasive Drilling And Styptic) protocol-A modified approach to treating patients under therapeutic anticoagulants | |
| Singha et al. | Evaluation of treatment outcome after impacted mandibular third molar surgery with and without autologous platelet concentrates | |
| Green | Hemophilia and von Willebrand disease: Factor VIII and von Willebrand Factor | |
| Simson et al. | Clinical evaluation of cryoprecipitated factor VIII | |
| Aprajita et al. | Guided bone regeneration using a platelet-rich fibrin membrane and sticky bone graft along with implant placement in maxillary anterior region: a case report | |
| Findik et al. | Secondary closure of alveolar clefts with mandibular symphyseal bone grafts and with platelet-rich fibrin under local anesthesia: three case reports | |
| Singh et al. | Profile changes after conventional and chin shield genioplasty | |
| Mourão et al. | New and improved platelet-rich fibrin membranes | |
| Storti et al. | Epsilon-aminocaproic acid for synovectomy in haemophilic patients | |
| Maraqa et al. | Effect of mineralized plasmatic matrix (MPM) platelet concentrate versus platelet-rich fibrin for socket preservation: Comparative study | |
| Kumeti et al. | 2.0 mm 3D VERSES 2.0 mm MINI PLATES IN MANDIBULAR FRACTURES | |
| Vignesh et al. | Management of Haemorrhage in Oral Surgery | |
| Stephen et al. | Assessment of knowledge, awareness, and perception of platelet-rich plasma among oral surgeons |